Hong Xiaonan相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial

来那度胺联合R-CHOP方案（R2-CHOP）治疗新诊断的双表达弥漫性大B细胞淋巴瘤：一项前瞻性II期临床试验

期刊:Blood Cancer Journal

影响因子:11.6

doi:10.1038/s41408-025-01229-5

Liu, Yizhen; Zhang, Qunling; Lv, Fangfang; Liu, Xiaojian; Ji, Dongmei; Xia, Zuguang; Jin, Jia; Tao, Rong; Zhang, Wenhao; Li, Xiaoqiu; Zhang, Shengjian; Wang, Zezhou; Wang, Jiachen; Hong, Xiaonan; Cao, Junning

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Predicting central nervous system relapse in primary breast diffuse large B-cell lymphoma using the stage-modified IPI score: A retrospective cohort study

利用分期改良的IPI评分预测原发性乳腺弥漫性大B细胞淋巴瘤中枢神经系统复发：一项回顾性队列研究

影响因子:3.6

doi:10.1016/j.heliyon.2024.e26795

Chen, Guang-Liang; Guo, Pin; Wang, Jin; Yu, Bao-Hua; Hong, Xiaonan; Cao, Junning; Lv, Fangfang

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study

西达米德联合R-GDP治疗不适合自体移植的复发/难治性弥漫性大B细胞淋巴瘤患者：一项前瞻性、单臂、II期研究

期刊:Cancer Medicine

影响因子:3.1

doi:10.1002/cam4.70142

Chen, Guang-Liang; Xue, Kai; Zhang, Qunling; Xia, Zu-Guang; Jin, Jia; Li, Ran; Liu, Yizhen; Lv, Fangfang; Hong, Xiaonan; Li, Xiaoqiu; Cao, Junning

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study

GOYA研究中，总代谢肿瘤体积作为弥漫性大B细胞淋巴瘤患者生存预测因子

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2021.278663

Kostakoglu, Lale; Mattiello, Federico; Martelli, Maurizio; Sehn, Laurie H; Belada, David; Ghiggi, Chiara; Chua, Neil; González-Barca, Eva; Hong, Xiaonan; Pinto, Antonio; Shi, Yuankai; Tatsumi, Yoichi; Bolen, Christopher; Knapp, Andrea; Sellam, Gila; Nielsen, Tina; Sahin, Deniz; Vitolo, Umberto; Trněný, Marek

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera(®)) in patients with CD20-positive B-cell non-Hodgkin lymphoma

一项多中心、开放标签、随机、平行对照的II期研究，比较了利妥昔单抗（SCT400）与利妥昔单抗（美罗华®）在CD20阳性B细胞非霍奇金淋巴瘤患者中的药代动力学、药效学和安全性。

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.21147/j.issn.1000-9604.2022.06.08

Han, Xiaohong; Zhang, Mingzhi; Wang, Huaqing; Zhang, Qingyuan; Li, Wei; Hao, Miaowang; Gao, Yuhuan; Jin, Jie; Ren, Hanyun; Tang, Yun; Hong, Xiaonan; Ke, Xiaoyan; Su, Hang; Gui, Lin; Luo, Jianmin; Xie, Liangzhi; Gai, Wenlin; Shi, Yuankai

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

四个疗程的 R-CHOP 方案化疗后，根据中期 PET/CT 检查结果阴性，进行两次利妥昔单抗治疗：一项前瞻性试验的分析

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-022-09486-4

Jin, Jia; Ji, Dongmei; Xia, Zuguang; Xue, Kai; Zhang, Qunling; Liu, Yizhen; Cao, Junning; Hong, Xiaonan; Gu, Juan J; Guo, Ye; Lv, Fangfang

发表日期：2022

文献求助收藏

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma

原发性乳腺弥漫性大B细胞淋巴瘤的临床特征和预后因素

期刊:Mediterranean Journal of Hematology and Infectious Diseases

影响因子:1.5

doi:10.4084/MJHID.2022.066

Chen, Guang-Liang; Li, Doudou; Cao, Sufen; Jiang, Shiyu; Zhang, Qunling; Jin, Jia; Xia, Zuguang; Liu, Yizhen; Liu, Xiaojian; Zhu, Yanzhe; Chen, Yu; Gu, Lingli; Hong, Xiaonan; Cao, Junning; Tao, Rong; Lv, Fangfang

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

Prognostic significance of clinical characteristics and (18)Fluorodeoxyglucose-positron emission tomography/computed tomography quantitative parameters in patients with primary mediastinal B-cell lymphoma

临床特征和（18）氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描定量参数在原发性纵隔B细胞淋巴瘤患者中的预后意义

期刊:Journal of International Medical Research

影响因子:1.5

doi:10.1177/03000605211063027

Liu, Yizhen; Jiang, Jinjin; Liu, Lianfang; Wang, Zezhou; Yu, Baohua; Xia, Zuguang; Zhang, Qunling; Ji, Dongmei; Liu, Xiaojian; Lv, Fangfang; Hong, Xiaonan; Song, Shaoli; Cao, Junning

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial

伊布替尼和利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松治疗既往未接受治疗的非生发中心B细胞样弥漫性大B细胞淋巴瘤患者：PHOENIX III期试验的中国亚组分析

影响因子:1.2

doi:10.1002/jha2.517

Zhu, Jun; Hong, Xiaonan; Song, Yu Qin; Hodkinson, Brendan; Balasubramanian, Sriram; Wang, Songbai; Zhang, Qingyuan; Shi, Yuankai; Huang, Huiqiang; Zhang, Huilai; Zhu, Yan; Shreeve, Stephen Martin; Sun, Steven; Wang, Ze; Wang, Xiaocan; Fan, Yue; Wilson, Wyndham; Vermeulen, Jessica

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

ROBUST：一项比较来那度胺联合R-CHOP方案与安慰剂联合R-CHOP方案治疗既往未接受治疗的ABC型弥漫性大B细胞淋巴瘤患者的III期研究

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.20.01366

Nowakowski, Grzegorz S; Chiappella, Annalisa; Gascoyne, Randy D; Scott, David W; Zhang, Qingyuan; Jurczak, Wojciech; Özcan, Muhit; Hong, Xiaonan; Zhu, Jun; Jin, Jie; Belada, David; Bergua, Juan Miguel; Piazza, Francesco; Mócikova, Heidi; Molinari, Anna Lia; Yoon, Dok Hyun; Cavallo, Federica; Tani, Monica; Yamamoto, Kazuhito; Izutsu, Koji; Kato, Koji; Czuczman, Myron; Hersey, Sarah; Kilcoyne, Adrian; Russo, Jacqueline; Hudak, Krista; Zhang, Jingshan; Wade, Steve; Witzig, Thomas E; Vitolo, Umberto

细胞生物学

免疫/内分泌

发表日期：2021

文献求助收藏